Waldencast (NASDAQ:WALD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler [Yahoo! Finance]
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
Waldencast (NASDAQ:WALD) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Waldencast (NASDAQ:WALD) was given a new $2.00 price target on by analysts at Jefferies Financial Group Inc..